Clinical characteristics analysis of polycystic ovary syndrome with syndrome of phlegm dampness
XU Fang1 HOU Lihui1 LIU Yinghua2 WANG Mengsi1 DING Chunli1 NIU Jingyun1
1.Department of Gynaecology and Obstetrics, the First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Heilongjiang Province, Harbin 150040, China; 2.Department of Gynaecology and Obstetrics, the Affiliated Hospital of Liaoning University of TCM, Liaoning Province, Shenyang 110023, China
Abstract：Objective To investigate the clinical characteristics, sex hormones and glucose and lipid metabolism characteristics of PCOS patients with syndrome of phlegm dampness. Methods From September 2013 to August 2015, the data of gynecological outpatient patients with PCOS from Clinical Research Information Integration System of First Affiliated Hospital, Heilongjiang University of Chinese Medicine were analyzed retrospectively. All the patients were divided into two groups according to the diagnostic criteria of PCOS with syndrome of phlegm dampness. The clinical characteristics, sex hormones and abnormal metabolism of glucose and lipid were compared and analyzed. Results Among 617 cases of PCOS, 393 cases (63.7%) were PCOS with syndrome of phlegm dampness, and 224 cases (36.3%) were non phlegm dampness. The body mass index, waist hip ratio, systolic blood pressure, diastolic blood pressure, incidence of acanthosis, excessive fat, insulin resistance, impaired glucose tolerance, testosterone, fasting blood glucose, fasting insulin, insulin resistance index, total cholesterol, triglyceride, low density lipoprotein cholesterol, total cholesterol high density lipoprotein, triglyceride/high density lipoprotein cholesterol, low density lipoprotein cholesterol/high density lipoprotein cholesterol and lipid accumulation index in the phlegm dampness syndrome PCOS group were higher than those in non phlegm dampness syndrome PCOS group (P < 0.05). The hairy incidence, luteinizing hormone, follicle stimulating hormone, luteinizing hormone/follicle stimulating hormone, sex hormone binding globulin, high density lipoprotein cholesterol levels in phlegm dampness PCOS group were lower than those in the non phlegm dampness syndrome PCOS group (P < 0.05). Conclusion Phlegm dampness syndrome is one of the main syndromes of PCOS patients; PCOS patients with syndrome of phlegm dampness have obvious sex hormones and glucose and lipid metabolism abnormality. Besides insulin resistance is an important metabolic characteristic of PCOS with syndrome of phlegm dampness.
[1] 李亚茜，俞超芹，翟东霞，等.基于文献多囊卵巢综合征中医证候规律研究初探[J].中国中医基础医学杂志，2015， 21（9）：1081-1082.
[2] 刘新敏，华强.从现代文献探讨多囊卵巢综合征的中医证候及证候要素分布特点[J].中国中医药信息杂志，2011， 18（2）：34-36.
[3] Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndroeme（PCOS）[J]. Hum Reprod，2004，19（1）：41-47.
[4] 国家中医药管理局医政司.24个专业105个病种中医临床路径（试行）[M].北京：国家中医药管理局，2012.
[5] 马宝璋.中医妇科学[M].上海：上海科学技术出版社，2003.
[6] 常久，李晓君.多囊卵巢综合征中医证型分布特点的现代文献研究[J].中国性科学，2014，23（3）：60-63
[7] 严炜，黄慧芬.多囊卵巢综合征中医证型与性激素水平、胰岛素抵抗关系的研究[J].世界中西医结合杂志，2009， 4（4）：274-276.
[8] 唐培培，谈勇.多囊卵巢综合征中医证型分布规律及性激素水平、糖代谢特点[J].中国中西医结合杂志，2016， 36（7）：801-805.
[9] 乔世聪，侯丽辉，王鑫，等.多囊卵巢综合征患者人体测量学指标与中医证型相关性的研究[J].实用医学杂志，2015，31（1）：147-149.
[10] 李玲孺，王济，李英帅，等.从痰湿体质角度研究肥胖亚型[J].世界中医药，2013，8（1）：18-20.
[11] Karabulut A，Yaylali GF，Denirlenk S，et al. Evaluation of body fat distribution in PCOS and its association with carotid atherosclerosis and insulin resistance [J]. Gynecol Endocrinol，2012，28（2）：111-114.
[12] Lim SS，Davies MJ，Norman RJ，et al. Overweight，obesity and central obesity in women with polycystic ovary syndrome：a systematic review and meta-analysis [J]. Hum Reprod Update，2012，18（6）：618-637.
[13] Gateva AT，Kamenov ZA. Markers of visceral obesity and cardiovascular risk in patients with polycystic ovarian syndrome [J]. Eur J Obstet Gynecol Reprod Biol，2012， 164（2）：161-166.
[14] Legro RS，Arslanian SA，Ehrmann DA，et al. Diagnosis and treatment of polycystic ovary syndrome：an Endocrine Society clinical practice guideline [J]. J Clin Endo crinol Metab，2013，98（12）：4565-4592.
[15] de Avila MA，Borges LP，Paez MS，et al. Acanthosis nigricans：metabolic interrelations inherent to the polycystic ovary syndrome [J]. Rev Bras Ginecol Obstet，2014，36（9）：410-415.
[16] Schmidt TH，Khanijow K，Cedars MI，et al. Cutaneous findings and systemic associations in women with polycystic ovary syndrome [J]. JAMA Dermatol，2016，152（4）：391-398.
[17] Hong JS，Kwon HH，Park SY，et al. Cutaneous manifestations of the subtypes of polycystic ovary syndrome in Korean patients [J]. J Eur Acad Dermatol Venereol，2015， 29（1）：42-47.
[18] Esmaeilzadeh S，Andarieh MG，Ghadimi R，et al. Body mass index and gonadotropin hormones（LH & FSH）associate with clinical symptoms among women with polycystic ovary syndrome [J]. Glob J Health Sci，2014，7（2）：101-106.
[19] 刘颖华，侯丽辉，徐芳，等.不同性激素结合球蛋白水平对多囊卵巢综合征患者的影响[J].实用医学杂志，2016， 30（12）：1969-1971.
[20] Lin XF，Wu RR，Du J，et al. Exploring the significance of sex hormone-binding globulin examination in the treatment of women with polycystic ovarian syndrome（PCOS）[J]. Clin Exp Obstet Gynecol，2015，42（3）：315-320.
[21] 李玉婷，何援利，朱洪磊.多囊卵巢综合征患者血清apoB/apoAⅠ比值对代谢综合征的诊断价值[J].解放军医学杂志，2013，38（6）：485-488.
[22] Bozic-Antic I，Ilic D， Bjekic-Macut J，et al. Lipid accumulation product as a marker of cardiometabolic susceptibility in women with different phenotypes of polycystic ovary syndrome [J]. Eur J Endocrinol，2016，175（6）：551-560.
[23] 李扬璐，阮祥燕，崔亚美，等.四中血清脂蛋白比值对多囊卵巢综合征患者发生代谢综合征的诊断预测价值[J].首都医科大学学报，2015，36（4）：559-566.
2018, Vol. 15 
京公网安备 11010502046598号